InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Explore the detailed record of transactions filed by McAnear Justin J., Chief Financial Officer. Officer active across 1 companies, notably 10x Genomics, Inc.. Cumulatively, 28 filings have been published. Total volume traded: €219k. The latest transaction was disclosed on 23 May 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations28 total
€44,144967 shares@ €45.65050.0021% mcap4.5% of flow
Class A Common Stock
SEC:0001567619-22-011713:0·
€6,163158 shares@ €39.00490.0003% mcap0.6% of flow
Class A Common Stock
SEC:0001567619-22-011123:0·
Ideal exit: 7 Feb 2023 (T+270)
021,357 shares0
Class A Common Stock
SEC:0001567619-22-007440:0·
€20,015288 shares@ €69.49760.0010% mcap2.0% of flow
Class A Common Stock
SEC:0001567619-22-005520:0·
€44,31410,000 shares@ €4.43140.0021% mcap9.6% of flow
Class A Common Stock
SEC:0001567619-22-000622·
€44,31410,000 shares@ €4.43140.0021% mcap4.5% of flow
Class A Common Stock
SEC:0001567619-22-000622:0·
€44,48310,000 shares@ €4.44830.0021% mcap9.7% of flow
Class A Common Stock
SEC:0001567619-21-021618·
€44,48310,000 shares@ €4.44830.0021% mcap4.5% of flow
Class A Common Stock
SEC:0001567619-21-021618:0·
€36,978281 shares@ €131.59330.0018% mcap8.0% of flow
Class A Common Stock
SEC:0001567619-21-021189·
€36,978281 shares@ €131.59330.0018% mcap3.7% of flow
Class A Common Stock
SEC:0001567619-21-021189:0·
€43,61110,000 shares@ €4.36110.0021% mcap9.5% of flow
Class A Common Stock
SEC:0001567619-21-019299·
€43,61110,000 shares@ €4.36110.0021% mcap4.4% of flow
Class A Common Stock
SEC:0001567619-21-019299:0·
€43,54410,000 shares@ €4.35440.0021% mcap9.5% of flow
Class A Common Stock
SEC:0001567619-21-017949·
€43,54410,000 shares@ €4.35440.0021% mcap4.4% of flow
Class A Common Stock
SEC:0001567619-21-017949:0·
€42,56410,000 shares@ €4.25640.0020% mcap9.2% of flow
Class A Common Stock
SEC:0001209191-21-054900·
€42,56410,000 shares@ €4.25640.0020% mcap4.3% of flow
Class A Common Stock
SEC:0001209191-21-054900:0·
€37,208270 shares@ €137.80670.0018% mcap8.1% of flow
Class A Common Stock
SEC:0001209191-21-053392·
€37,208270 shares@ €137.80670.0018% mcap3.8% of flow
Class A Common Stock
SEC:0001209191-21-053392:0·
€42,44310,000 shares@ €4.24430.0020% mcap9.2% of flow
Class A Common Stock
SEC:0001209191-21-049650·
€42,44310,000 shares@ €4.24430.0020% mcap4.3% of flow
Class A Common Stock
SEC:0001209191-21-049650:0·
€42,54510,000 shares@ €4.25450.0020% mcap9.2% of flow
Class A Common Stock
SEC:0001209191-21-045475·
€42,54510,000 shares@ €4.25450.0020% mcap4.3% of flow
Class A Common Stock
SEC:0001209191-21-045475:0·
€41,25110,000 shares@ €4.12510.0020% mcap9.0% of flow
Class A Common Stock
SEC:0001209191-21-037902·
€41,25110,000 shares@ €4.12510.0020% mcap4.2% of flow
Class A Common Stock
SEC:0001209191-21-037902:0·
08,935 shares0
Class A Common Stock
SEC:0001209191-21-036102·
25 of 28 declarations
About McAnear Justin J.
Justin J. McAnear is an executive at 10x Genomics, Inc.
